nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—SRC—epilepsy syndrome	0.219	0.598	CbGaD
Trabectedin—CYP2C19—epilepsy syndrome	0.0847	0.231	CbGaD
Trabectedin—CYP2D6—epilepsy syndrome	0.0628	0.171	CbGaD
Trabectedin—CYP2E1—Felbamate—epilepsy syndrome	0.022	0.0501	CbGbCtD
Trabectedin—CYP2E1—Trimethadione—epilepsy syndrome	0.022	0.0501	CbGbCtD
Trabectedin—CYP2E1—Clonazepam—epilepsy syndrome	0.0187	0.0426	CbGbCtD
Trabectedin—CYP2E1—Rufinamide—epilepsy syndrome	0.0152	0.0347	CbGbCtD
Trabectedin—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0148	0.0338	CbGbCtD
Trabectedin—PTGS1—Diazepam—epilepsy syndrome	0.0145	0.0332	CbGbCtD
Trabectedin—CYP2C19—Felbamate—epilepsy syndrome	0.0138	0.0314	CbGbCtD
Trabectedin—CYP2C19—Trimethadione—epilepsy syndrome	0.0138	0.0314	CbGbCtD
Trabectedin—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0129	0.0295	CbGbCtD
Trabectedin—CYP2E1—Propofol—epilepsy syndrome	0.0124	0.0283	CbGbCtD
Trabectedin—CYP2E1—Phenobarbital—epilepsy syndrome	0.0119	0.0271	CbGbCtD
Trabectedin—CYP2E1—Midazolam—epilepsy syndrome	0.0117	0.0267	CbGbCtD
Trabectedin—PTGS1—Valproic Acid—epilepsy syndrome	0.0115	0.0262	CbGbCtD
Trabectedin—CYP2C9—Trimethadione—epilepsy syndrome	0.0114	0.0261	CbGbCtD
Trabectedin—CYP2E1—Diazepam—epilepsy syndrome	0.0112	0.0257	CbGbCtD
Trabectedin—CYP2C19—Clobazam—epilepsy syndrome	0.0112	0.0256	CbGbCtD
Trabectedin—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0108	0.0246	CbGbCtD
Trabectedin—CYP2C19—Carbamazepine—epilepsy syndrome	0.00929	0.0212	CbGbCtD
Trabectedin—CYP2C19—Primidone—epilepsy syndrome	0.00868	0.0198	CbGbCtD
Trabectedin—CYP2C19—Phenytoin—epilepsy syndrome	0.00834	0.019	CbGbCtD
Trabectedin—CYP2C19—Propofol—epilepsy syndrome	0.00778	0.0177	CbGbCtD
Trabectedin—CYP2C9—Carbamazepine—epilepsy syndrome	0.00773	0.0176	CbGbCtD
Trabectedin—CYP2C19—Phenobarbital—epilepsy syndrome	0.00743	0.017	CbGbCtD
Trabectedin—CYP2C9—Primidone—epilepsy syndrome	0.00721	0.0165	CbGbCtD
Trabectedin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00716	0.0163	CbGbCtD
Trabectedin—CYP2C19—Diazepam—epilepsy syndrome	0.00704	0.0161	CbGbCtD
Trabectedin—CYP2C9—Phenytoin—epilepsy syndrome	0.00693	0.0158	CbGbCtD
Trabectedin—CYP2C19—Zonisamide—epilepsy syndrome	0.00688	0.0157	CbGbCtD
Trabectedin—CYP3A4—Trimethadione—epilepsy syndrome	0.00665	0.0152	CbGbCtD
Trabectedin—CYP3A4—Felbamate—epilepsy syndrome	0.00665	0.0152	CbGbCtD
Trabectedin—CYP2C9—Propofol—epilepsy syndrome	0.00646	0.0148	CbGbCtD
Trabectedin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00625	0.0143	CbGbCtD
Trabectedin—CYP2C9—Phenobarbital—epilepsy syndrome	0.00618	0.0141	CbGbCtD
Trabectedin—CYP2D6—Propofol—epilepsy syndrome	0.00591	0.0135	CbGbCtD
Trabectedin—CYP2C9—Diazepam—epilepsy syndrome	0.00586	0.0134	CbGbCtD
Trabectedin—CYP3A4—Clonazepam—epilepsy syndrome	0.00566	0.0129	CbGbCtD
Trabectedin—CYP2C19—Valproic Acid—epilepsy syndrome	0.00555	0.0127	CbGbCtD
Trabectedin—CYP3A4—Clobazam—epilepsy syndrome	0.00542	0.0124	CbGbCtD
Trabectedin—CYP2C19—Topiramate—epilepsy syndrome	0.00501	0.0114	CbGbCtD
Trabectedin—CYP2C9—Valproic Acid—epilepsy syndrome	0.00462	0.0105	CbGbCtD
Trabectedin—CYP3A4—Rufinamide—epilepsy syndrome	0.00461	0.0105	CbGbCtD
Trabectedin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00449	0.0103	CbGbCtD
Trabectedin—CYP3A4—Primidone—epilepsy syndrome	0.00419	0.00958	CbGbCtD
Trabectedin—CYP3A4—Phenytoin—epilepsy syndrome	0.00403	0.0092	CbGbCtD
Trabectedin—CYP3A4—Propofol—epilepsy syndrome	0.00376	0.00858	CbGbCtD
Trabectedin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00359	0.0082	CbGbCtD
Trabectedin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00359	0.0082	CbGbCtD
Trabectedin—CYP3A4—Midazolam—epilepsy syndrome	0.00354	0.00809	CbGbCtD
Trabectedin—CYP3A4—Diazepam—epilepsy syndrome	0.00341	0.00777	CbGbCtD
Trabectedin—CYP3A4—Zonisamide—epilepsy syndrome	0.00332	0.00759	CbGbCtD
Trabectedin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00268	0.00613	CbGbCtD
Trabectedin—CYP3A4—Topiramate—epilepsy syndrome	0.00242	0.00553	CbGbCtD
Trabectedin—SRC—forebrain—epilepsy syndrome	0.000184	0.082	CbGeAlD
Trabectedin—SRC—telencephalon—epilepsy syndrome	0.000169	0.0754	CbGeAlD
Trabectedin—PTGS1—ganglion—epilepsy syndrome	0.000164	0.0729	CbGeAlD
Trabectedin—SRC—spinal cord—epilepsy syndrome	0.000118	0.0528	CbGeAlD
Trabectedin—SRC—head—epilepsy syndrome	0.000105	0.0469	CbGeAlD
Trabectedin—CYP2D6—hindbrain—epilepsy syndrome	0.000102	0.0455	CbGeAlD
Trabectedin—SRC—nervous system—epilepsy syndrome	9.98e-05	0.0445	CbGeAlD
Trabectedin—SRC—central nervous system—epilepsy syndrome	9.61e-05	0.0428	CbGeAlD
Trabectedin—SRC—cerebellum—epilepsy syndrome	9.39e-05	0.0419	CbGeAlD
Trabectedin—SRC—brain—epilepsy syndrome	7.63e-05	0.034	CbGeAlD
Trabectedin—Dizziness—Fosphenytoin—epilepsy syndrome	7.43e-05	0.00058	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	7.43e-05	0.00058	CcSEcCtD
Trabectedin—Dermatitis—Midazolam—epilepsy syndrome	7.43e-05	0.00058	CcSEcCtD
Trabectedin—Vomiting—Levetiracetam—epilepsy syndrome	7.4e-05	0.000578	CcSEcCtD
Trabectedin—Alopecia—Gabapentin—epilepsy syndrome	7.39e-05	0.000577	CcSEcCtD
Trabectedin—Headache—Midazolam—epilepsy syndrome	7.39e-05	0.000576	CcSEcCtD
Trabectedin—Abdominal pain—Carbamazepine—epilepsy syndrome	7.38e-05	0.000576	CcSEcCtD
Trabectedin—Body temperature increased—Carbamazepine—epilepsy syndrome	7.38e-05	0.000576	CcSEcCtD
Trabectedin—Diarrhoea—Diazepam—epilepsy syndrome	7.38e-05	0.000576	CcSEcCtD
Trabectedin—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	7.38e-05	0.000576	CcSEcCtD
Trabectedin—Rash—Levetiracetam—epilepsy syndrome	7.34e-05	0.000573	CcSEcCtD
Trabectedin—Anaemia—Pregabalin—epilepsy syndrome	7.34e-05	0.000573	CcSEcCtD
Trabectedin—Dermatitis—Levetiracetam—epilepsy syndrome	7.33e-05	0.000572	CcSEcCtD
Trabectedin—Asthenia—Zonisamide—epilepsy syndrome	7.33e-05	0.000572	CcSEcCtD
Trabectedin—Mental disorder—Gabapentin—epilepsy syndrome	7.33e-05	0.000572	CcSEcCtD
Trabectedin—Agranulocytosis—Topiramate—epilepsy syndrome	7.32e-05	0.000571	CcSEcCtD
Trabectedin—Headache—Levetiracetam—epilepsy syndrome	7.29e-05	0.000569	CcSEcCtD
Trabectedin—Malnutrition—Gabapentin—epilepsy syndrome	7.28e-05	0.000568	CcSEcCtD
Trabectedin—Hypersensitivity—Clonazepam—epilepsy syndrome	7.25e-05	0.000566	CcSEcCtD
Trabectedin—Dizziness—Vigabatrin—epilepsy syndrome	7.24e-05	0.000565	CcSEcCtD
Trabectedin—Hypersensitivity—Phenytoin—epilepsy syndrome	7.2e-05	0.000562	CcSEcCtD
Trabectedin—Oedema—Valproic Acid—epilepsy syndrome	7.17e-05	0.000559	CcSEcCtD
Trabectedin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.17e-05	0.000559	CcSEcCtD
Trabectedin—Nausea—Propofol—epilepsy syndrome	7.16e-05	0.000559	CcSEcCtD
Trabectedin—Vomiting—Fosphenytoin—epilepsy syndrome	7.14e-05	0.000558	CcSEcCtD
Trabectedin—Diarrhoea—Felbamate—epilepsy syndrome	7.14e-05	0.000557	CcSEcCtD
Trabectedin—Abdominal pain—Lamotrigine—epilepsy syndrome	7.13e-05	0.000557	CcSEcCtD
Trabectedin—Body temperature increased—Lamotrigine—epilepsy syndrome	7.13e-05	0.000557	CcSEcCtD
Trabectedin—Dysgeusia—Gabapentin—epilepsy syndrome	7.13e-05	0.000556	CcSEcCtD
Trabectedin—Dizziness—Diazepam—epilepsy syndrome	7.13e-05	0.000556	CcSEcCtD
Trabectedin—Infection—Valproic Acid—epilepsy syndrome	7.12e-05	0.000556	CcSEcCtD
Trabectedin—Syncope—Pregabalin—epilepsy syndrome	7.12e-05	0.000556	CcSEcCtD
Trabectedin—Leukopenia—Pregabalin—epilepsy syndrome	7.11e-05	0.000555	CcSEcCtD
Trabectedin—Rash—Fosphenytoin—epilepsy syndrome	7.08e-05	0.000553	CcSEcCtD
Trabectedin—Dermatitis—Fosphenytoin—epilepsy syndrome	7.08e-05	0.000552	CcSEcCtD
Trabectedin—Haemoglobin—Topiramate—epilepsy syndrome	7.07e-05	0.000552	CcSEcCtD
Trabectedin—Asthenia—Clonazepam—epilepsy syndrome	7.06e-05	0.000551	CcSEcCtD
Trabectedin—Back pain—Gabapentin—epilepsy syndrome	7.04e-05	0.00055	CcSEcCtD
Trabectedin—Headache—Fosphenytoin—epilepsy syndrome	7.04e-05	0.000549	CcSEcCtD
Trabectedin—Haemorrhage—Topiramate—epilepsy syndrome	7.04e-05	0.000549	CcSEcCtD
Trabectedin—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.03e-05	0.000549	CcSEcCtD
Trabectedin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	7.02e-05	0.000548	CcSEcCtD
Trabectedin—Asthenia—Phenytoin—epilepsy syndrome	7.02e-05	0.000548	CcSEcCtD
Trabectedin—Nausea—Midazolam—epilepsy syndrome	7e-05	0.000546	CcSEcCtD
Trabectedin—Diarrhoea—Zonisamide—epilepsy syndrome	6.99e-05	0.000545	CcSEcCtD
Trabectedin—Loss of consciousness—Pregabalin—epilepsy syndrome	6.98e-05	0.000545	CcSEcCtD
Trabectedin—Asthenia—Oxcarbazepine—epilepsy syndrome	6.98e-05	0.000545	CcSEcCtD
Trabectedin—Vomiting—Vigabatrin—epilepsy syndrome	6.96e-05	0.000543	CcSEcCtD
Trabectedin—Skin disorder—Valproic Acid—epilepsy syndrome	6.96e-05	0.000543	CcSEcCtD
Trabectedin—Oedema peripheral—Topiramate—epilepsy syndrome	6.93e-05	0.000541	CcSEcCtD
Trabectedin—Cough—Pregabalin—epilepsy syndrome	6.93e-05	0.000541	CcSEcCtD
Trabectedin—Connective tissue disorder—Topiramate—epilepsy syndrome	6.92e-05	0.00054	CcSEcCtD
Trabectedin—Nausea—Levetiracetam—epilepsy syndrome	6.91e-05	0.00054	CcSEcCtD
Trabectedin—Rash—Vigabatrin—epilepsy syndrome	6.91e-05	0.000539	CcSEcCtD
Trabectedin—Dizziness—Felbamate—epilepsy syndrome	6.9e-05	0.000539	CcSEcCtD
Trabectedin—Dermatitis—Vigabatrin—epilepsy syndrome	6.9e-05	0.000538	CcSEcCtD
Trabectedin—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.88e-05	0.000537	CcSEcCtD
Trabectedin—PTGS1—forebrain—epilepsy syndrome	6.86e-05	0.0306	CbGeAlD
Trabectedin—Headache—Vigabatrin—epilepsy syndrome	6.86e-05	0.000535	CcSEcCtD
Trabectedin—Vomiting—Diazepam—epilepsy syndrome	6.86e-05	0.000535	CcSEcCtD
Trabectedin—Anorexia—Valproic Acid—epilepsy syndrome	6.83e-05	0.000533	CcSEcCtD
Trabectedin—Rash—Diazepam—epilepsy syndrome	6.8e-05	0.000531	CcSEcCtD
Trabectedin—Dermatitis—Diazepam—epilepsy syndrome	6.79e-05	0.00053	CcSEcCtD
Trabectedin—Arthralgia—Pregabalin—epilepsy syndrome	6.76e-05	0.000528	CcSEcCtD
Trabectedin—Myalgia—Pregabalin—epilepsy syndrome	6.76e-05	0.000528	CcSEcCtD
Trabectedin—Dizziness—Zonisamide—epilepsy syndrome	6.75e-05	0.000527	CcSEcCtD
Trabectedin—Headache—Diazepam—epilepsy syndrome	6.75e-05	0.000527	CcSEcCtD
Trabectedin—Diarrhoea—Clonazepam—epilepsy syndrome	6.74e-05	0.000526	CcSEcCtD
Trabectedin—Anaemia—Gabapentin—epilepsy syndrome	6.73e-05	0.000525	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.71e-05	0.000524	CcSEcCtD
Trabectedin—Hypotension—Valproic Acid—epilepsy syndrome	6.7e-05	0.000523	CcSEcCtD
Trabectedin—Asthenia—Carbamazepine—epilepsy syndrome	6.7e-05	0.000523	CcSEcCtD
Trabectedin—Diarrhoea—Phenytoin—epilepsy syndrome	6.69e-05	0.000522	CcSEcCtD
Trabectedin—Nausea—Fosphenytoin—epilepsy syndrome	6.67e-05	0.000521	CcSEcCtD
Trabectedin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.66e-05	0.000519	CcSEcCtD
Trabectedin—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.65e-05	0.000519	CcSEcCtD
Trabectedin—Vomiting—Felbamate—epilepsy syndrome	6.63e-05	0.000518	CcSEcCtD
Trabectedin—Rash—Felbamate—epilepsy syndrome	6.58e-05	0.000514	CcSEcCtD
Trabectedin—Dermatitis—Felbamate—epilepsy syndrome	6.57e-05	0.000513	CcSEcCtD
Trabectedin—CYP2E1—telencephalon—epilepsy syndrome	6.55e-05	0.0292	CbGeAlD
Trabectedin—Headache—Felbamate—epilepsy syndrome	6.54e-05	0.00051	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.53e-05	0.00051	CcSEcCtD
Trabectedin—Flushing—Topiramate—epilepsy syndrome	6.53e-05	0.00051	CcSEcCtD
Trabectedin—Syncope—Gabapentin—epilepsy syndrome	6.53e-05	0.00051	CcSEcCtD
Trabectedin—Leukopenia—Gabapentin—epilepsy syndrome	6.52e-05	0.000509	CcSEcCtD
Trabectedin—Dizziness—Clonazepam—epilepsy syndrome	6.51e-05	0.000508	CcSEcCtD
Trabectedin—Nausea—Vigabatrin—epilepsy syndrome	6.51e-05	0.000508	CcSEcCtD
Trabectedin—Vomiting—Zonisamide—epilepsy syndrome	6.49e-05	0.000507	CcSEcCtD
Trabectedin—Insomnia—Valproic Acid—epilepsy syndrome	6.48e-05	0.000506	CcSEcCtD
Trabectedin—Oedema—Pregabalin—epilepsy syndrome	6.48e-05	0.000506	CcSEcCtD
Trabectedin—Asthenia—Lamotrigine—epilepsy syndrome	6.47e-05	0.000505	CcSEcCtD
Trabectedin—Dizziness—Phenytoin—epilepsy syndrome	6.47e-05	0.000505	CcSEcCtD
Trabectedin—Rash—Zonisamide—epilepsy syndrome	6.44e-05	0.000503	CcSEcCtD
Trabectedin—Infection—Pregabalin—epilepsy syndrome	6.44e-05	0.000502	CcSEcCtD
Trabectedin—Paraesthesia—Valproic Acid—epilepsy syndrome	6.44e-05	0.000502	CcSEcCtD
Trabectedin—Dermatitis—Zonisamide—epilepsy syndrome	6.43e-05	0.000502	CcSEcCtD
Trabectedin—Dizziness—Oxcarbazepine—epilepsy syndrome	6.43e-05	0.000502	CcSEcCtD
Trabectedin—Nausea—Diazepam—epilepsy syndrome	6.4e-05	0.0005	CcSEcCtD
Trabectedin—Loss of consciousness—Gabapentin—epilepsy syndrome	6.4e-05	0.000499	CcSEcCtD
Trabectedin—Headache—Zonisamide—epilepsy syndrome	6.4e-05	0.000499	CcSEcCtD
Trabectedin—Dyspnoea—Valproic Acid—epilepsy syndrome	6.39e-05	0.000499	CcSEcCtD
Trabectedin—Diarrhoea—Carbamazepine—epilepsy syndrome	6.39e-05	0.000498	CcSEcCtD
Trabectedin—Angiopathy—Topiramate—epilepsy syndrome	6.38e-05	0.000498	CcSEcCtD
Trabectedin—Shock—Pregabalin—epilepsy syndrome	6.38e-05	0.000498	CcSEcCtD
Trabectedin—Nervous system disorder—Pregabalin—epilepsy syndrome	6.36e-05	0.000496	CcSEcCtD
Trabectedin—Cough—Gabapentin—epilepsy syndrome	6.35e-05	0.000496	CcSEcCtD
Trabectedin—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.35e-05	0.000495	CcSEcCtD
Trabectedin—Mediastinal disorder—Topiramate—epilepsy syndrome	6.34e-05	0.000495	CcSEcCtD
Trabectedin—Dyspepsia—Valproic Acid—epilepsy syndrome	6.31e-05	0.000492	CcSEcCtD
Trabectedin—PTGS1—telencephalon—epilepsy syndrome	6.31e-05	0.0281	CbGeAlD
Trabectedin—Skin disorder—Pregabalin—epilepsy syndrome	6.29e-05	0.000491	CcSEcCtD
Trabectedin—Vomiting—Clonazepam—epilepsy syndrome	6.26e-05	0.000489	CcSEcCtD
Trabectedin—Decreased appetite—Valproic Acid—epilepsy syndrome	6.23e-05	0.000486	CcSEcCtD
Trabectedin—Alopecia—Topiramate—epilepsy syndrome	6.22e-05	0.000485	CcSEcCtD
Trabectedin—Vomiting—Phenytoin—epilepsy syndrome	6.22e-05	0.000485	CcSEcCtD
Trabectedin—Rash—Clonazepam—epilepsy syndrome	6.21e-05	0.000484	CcSEcCtD
Trabectedin—Dermatitis—Clonazepam—epilepsy syndrome	6.2e-05	0.000484	CcSEcCtD
Trabectedin—Myalgia—Gabapentin—epilepsy syndrome	6.2e-05	0.000484	CcSEcCtD
Trabectedin—Arthralgia—Gabapentin—epilepsy syndrome	6.2e-05	0.000484	CcSEcCtD
Trabectedin—Nausea—Felbamate—epilepsy syndrome	6.2e-05	0.000484	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.19e-05	0.000483	CcSEcCtD
Trabectedin—Vomiting—Oxcarbazepine—epilepsy syndrome	6.18e-05	0.000483	CcSEcCtD
Trabectedin—Fatigue—Valproic Acid—epilepsy syndrome	6.18e-05	0.000482	CcSEcCtD
Trabectedin—Anorexia—Pregabalin—epilepsy syndrome	6.18e-05	0.000482	CcSEcCtD
Trabectedin—Dizziness—Carbamazepine—epilepsy syndrome	6.17e-05	0.000482	CcSEcCtD
Trabectedin—Diarrhoea—Lamotrigine—epilepsy syndrome	6.17e-05	0.000482	CcSEcCtD
Trabectedin—Headache—Clonazepam—epilepsy syndrome	6.17e-05	0.000481	CcSEcCtD
Trabectedin—Rash—Phenytoin—epilepsy syndrome	6.17e-05	0.000481	CcSEcCtD
Trabectedin—Mental disorder—Topiramate—epilepsy syndrome	6.17e-05	0.000481	CcSEcCtD
Trabectedin—Dermatitis—Phenytoin—epilepsy syndrome	6.16e-05	0.000481	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.16e-05	0.00048	CcSEcCtD
Trabectedin—Rash—Oxcarbazepine—epilepsy syndrome	6.13e-05	0.000479	CcSEcCtD
Trabectedin—Constipation—Valproic Acid—epilepsy syndrome	6.13e-05	0.000478	CcSEcCtD
Trabectedin—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.13e-05	0.000478	CcSEcCtD
Trabectedin—Headache—Phenytoin—epilepsy syndrome	6.13e-05	0.000478	CcSEcCtD
Trabectedin—Malnutrition—Topiramate—epilepsy syndrome	6.13e-05	0.000478	CcSEcCtD
Trabectedin—Headache—Oxcarbazepine—epilepsy syndrome	6.09e-05	0.000476	CcSEcCtD
Trabectedin—Nausea—Zonisamide—epilepsy syndrome	6.07e-05	0.000474	CcSEcCtD
Trabectedin—Hypotension—Pregabalin—epilepsy syndrome	6.06e-05	0.000473	CcSEcCtD
Trabectedin—Dysgeusia—Topiramate—epilepsy syndrome	6e-05	0.000468	CcSEcCtD
Trabectedin—Dizziness—Lamotrigine—epilepsy syndrome	5.97e-05	0.000466	CcSEcCtD
Trabectedin—Oedema—Gabapentin—epilepsy syndrome	5.94e-05	0.000464	CcSEcCtD
Trabectedin—Vomiting—Carbamazepine—epilepsy syndrome	5.93e-05	0.000463	CcSEcCtD
Trabectedin—Back pain—Topiramate—epilepsy syndrome	5.93e-05	0.000462	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.9e-05	0.000461	CcSEcCtD
Trabectedin—Infection—Gabapentin—epilepsy syndrome	5.9e-05	0.000461	CcSEcCtD
Trabectedin—Rash—Carbamazepine—epilepsy syndrome	5.89e-05	0.000459	CcSEcCtD
Trabectedin—Dermatitis—Carbamazepine—epilepsy syndrome	5.88e-05	0.000459	CcSEcCtD
Trabectedin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.86e-05	0.000457	CcSEcCtD
Trabectedin—Insomnia—Pregabalin—epilepsy syndrome	5.86e-05	0.000457	CcSEcCtD
Trabectedin—Nausea—Clonazepam—epilepsy syndrome	5.85e-05	0.000456	CcSEcCtD
Trabectedin—Headache—Carbamazepine—epilepsy syndrome	5.85e-05	0.000456	CcSEcCtD
Trabectedin—Shock—Gabapentin—epilepsy syndrome	5.85e-05	0.000456	CcSEcCtD
Trabectedin—CYP2D6—brainstem—epilepsy syndrome	5.84e-05	0.0261	CbGeAlD
Trabectedin—Nervous system disorder—Gabapentin—epilepsy syndrome	5.83e-05	0.000455	CcSEcCtD
Trabectedin—Paraesthesia—Pregabalin—epilepsy syndrome	5.82e-05	0.000454	CcSEcCtD
Trabectedin—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.82e-05	0.000454	CcSEcCtD
Trabectedin—Nausea—Phenytoin—epilepsy syndrome	5.81e-05	0.000453	CcSEcCtD
Trabectedin—Dyspnoea—Pregabalin—epilepsy syndrome	5.78e-05	0.000451	CcSEcCtD
Trabectedin—Nausea—Oxcarbazepine—epilepsy syndrome	5.78e-05	0.000451	CcSEcCtD
Trabectedin—Skin disorder—Gabapentin—epilepsy syndrome	5.77e-05	0.00045	CcSEcCtD
Trabectedin—Vomiting—Lamotrigine—epilepsy syndrome	5.74e-05	0.000448	CcSEcCtD
Trabectedin—Rash—Lamotrigine—epilepsy syndrome	5.69e-05	0.000444	CcSEcCtD
Trabectedin—Dermatitis—Lamotrigine—epilepsy syndrome	5.68e-05	0.000444	CcSEcCtD
Trabectedin—Body temperature increased—Valproic Acid—epilepsy syndrome	5.67e-05	0.000442	CcSEcCtD
Trabectedin—Abdominal pain—Valproic Acid—epilepsy syndrome	5.67e-05	0.000442	CcSEcCtD
Trabectedin—Anorexia—Gabapentin—epilepsy syndrome	5.66e-05	0.000442	CcSEcCtD
Trabectedin—Anaemia—Topiramate—epilepsy syndrome	5.66e-05	0.000442	CcSEcCtD
Trabectedin—Headache—Lamotrigine—epilepsy syndrome	5.65e-05	0.000441	CcSEcCtD
Trabectedin—CYP2D6—forebrain—epilepsy syndrome	5.64e-05	0.0251	CbGeAlD
Trabectedin—Decreased appetite—Pregabalin—epilepsy syndrome	5.63e-05	0.00044	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.59e-05	0.000437	CcSEcCtD
Trabectedin—Fatigue—Pregabalin—epilepsy syndrome	5.59e-05	0.000436	CcSEcCtD
Trabectedin—Hypotension—Gabapentin—epilepsy syndrome	5.55e-05	0.000433	CcSEcCtD
Trabectedin—Nausea—Carbamazepine—epilepsy syndrome	5.54e-05	0.000433	CcSEcCtD
Trabectedin—Constipation—Pregabalin—epilepsy syndrome	5.54e-05	0.000433	CcSEcCtD
Trabectedin—Syncope—Topiramate—epilepsy syndrome	5.49e-05	0.000429	CcSEcCtD
Trabectedin—Leukopenia—Topiramate—epilepsy syndrome	5.48e-05	0.000428	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.41e-05	0.000423	CcSEcCtD
Trabectedin—Loss of consciousness—Topiramate—epilepsy syndrome	5.38e-05	0.00042	CcSEcCtD
Trabectedin—Insomnia—Gabapentin—epilepsy syndrome	5.37e-05	0.000419	CcSEcCtD
Trabectedin—Nausea—Lamotrigine—epilepsy syndrome	5.36e-05	0.000418	CcSEcCtD
Trabectedin—Cough—Topiramate—epilepsy syndrome	5.35e-05	0.000417	CcSEcCtD
Trabectedin—Paraesthesia—Gabapentin—epilepsy syndrome	5.34e-05	0.000416	CcSEcCtD
Trabectedin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.3e-05	0.000414	CcSEcCtD
Trabectedin—Dyspnoea—Gabapentin—epilepsy syndrome	5.3e-05	0.000413	CcSEcCtD
Trabectedin—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.28e-05	0.000412	CcSEcCtD
Trabectedin—Dyspepsia—Gabapentin—epilepsy syndrome	5.23e-05	0.000408	CcSEcCtD
Trabectedin—Arthralgia—Topiramate—epilepsy syndrome	5.22e-05	0.000407	CcSEcCtD
Trabectedin—Myalgia—Topiramate—epilepsy syndrome	5.22e-05	0.000407	CcSEcCtD
Trabectedin—CYP2D6—telencephalon—epilepsy syndrome	5.19e-05	0.0231	CbGeAlD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.18e-05	0.000404	CcSEcCtD
Trabectedin—Decreased appetite—Gabapentin—epilepsy syndrome	5.17e-05	0.000403	CcSEcCtD
Trabectedin—CYP2E1—medulla oblongata—epilepsy syndrome	5.15e-05	0.0229	CbGeAlD
Trabectedin—Asthenia—Valproic Acid—epilepsy syndrome	5.14e-05	0.000401	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.13e-05	0.0004	CcSEcCtD
Trabectedin—Fatigue—Gabapentin—epilepsy syndrome	5.12e-05	0.0004	CcSEcCtD
Trabectedin—Abdominal pain—Pregabalin—epilepsy syndrome	5.12e-05	0.0004	CcSEcCtD
Trabectedin—Body temperature increased—Pregabalin—epilepsy syndrome	5.12e-05	0.0004	CcSEcCtD
Trabectedin—Constipation—Gabapentin—epilepsy syndrome	5.08e-05	0.000397	CcSEcCtD
Trabectedin—Oedema—Topiramate—epilepsy syndrome	5e-05	0.00039	CcSEcCtD
Trabectedin—Infection—Topiramate—epilepsy syndrome	4.97e-05	0.000388	CcSEcCtD
Trabectedin—Shock—Topiramate—epilepsy syndrome	4.92e-05	0.000384	CcSEcCtD
Trabectedin—Diarrhoea—Valproic Acid—epilepsy syndrome	4.9e-05	0.000383	CcSEcCtD
Trabectedin—Nervous system disorder—Topiramate—epilepsy syndrome	4.9e-05	0.000383	CcSEcCtD
Trabectedin—Thrombocytopenia—Topiramate—epilepsy syndrome	4.9e-05	0.000382	CcSEcCtD
Trabectedin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.86e-05	0.000379	CcSEcCtD
Trabectedin—Skin disorder—Topiramate—epilepsy syndrome	4.86e-05	0.000379	CcSEcCtD
Trabectedin—Hypersensitivity—Pregabalin—epilepsy syndrome	4.77e-05	0.000373	CcSEcCtD
Trabectedin—Anorexia—Topiramate—epilepsy syndrome	4.77e-05	0.000372	CcSEcCtD
Trabectedin—Dizziness—Valproic Acid—epilepsy syndrome	4.74e-05	0.00037	CcSEcCtD
Trabectedin—Body temperature increased—Gabapentin—epilepsy syndrome	4.7e-05	0.000367	CcSEcCtD
Trabectedin—Abdominal pain—Gabapentin—epilepsy syndrome	4.7e-05	0.000367	CcSEcCtD
Trabectedin—Hypotension—Topiramate—epilepsy syndrome	4.67e-05	0.000365	CcSEcCtD
Trabectedin—Asthenia—Pregabalin—epilepsy syndrome	4.65e-05	0.000363	CcSEcCtD
Trabectedin—CYP2E1—spinal cord—epilepsy syndrome	4.59e-05	0.0205	CbGeAlD
Trabectedin—Vomiting—Valproic Acid—epilepsy syndrome	4.56e-05	0.000356	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.56e-05	0.000355	CcSEcCtD
Trabectedin—Insomnia—Topiramate—epilepsy syndrome	4.52e-05	0.000353	CcSEcCtD
Trabectedin—Rash—Valproic Acid—epilepsy syndrome	4.52e-05	0.000353	CcSEcCtD
Trabectedin—Dermatitis—Valproic Acid—epilepsy syndrome	4.52e-05	0.000352	CcSEcCtD
Trabectedin—Headache—Valproic Acid—epilepsy syndrome	4.49e-05	0.00035	CcSEcCtD
Trabectedin—Paraesthesia—Topiramate—epilepsy syndrome	4.49e-05	0.00035	CcSEcCtD
Trabectedin—Dyspnoea—Topiramate—epilepsy syndrome	4.46e-05	0.000348	CcSEcCtD
Trabectedin—Diarrhoea—Pregabalin—epilepsy syndrome	4.43e-05	0.000346	CcSEcCtD
Trabectedin—PTGS1—spinal cord—epilepsy syndrome	4.42e-05	0.0197	CbGeAlD
Trabectedin—Dyspepsia—Topiramate—epilepsy syndrome	4.4e-05	0.000343	CcSEcCtD
Trabectedin—Hypersensitivity—Gabapentin—epilepsy syndrome	4.38e-05	0.000342	CcSEcCtD
Trabectedin—Decreased appetite—Topiramate—epilepsy syndrome	4.35e-05	0.000339	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.32e-05	0.000337	CcSEcCtD
Trabectedin—Fatigue—Topiramate—epilepsy syndrome	4.31e-05	0.000336	CcSEcCtD
Trabectedin—Dizziness—Pregabalin—epilepsy syndrome	4.29e-05	0.000334	CcSEcCtD
Trabectedin—Constipation—Topiramate—epilepsy syndrome	4.28e-05	0.000334	CcSEcCtD
Trabectedin—Asthenia—Gabapentin—epilepsy syndrome	4.26e-05	0.000333	CcSEcCtD
Trabectedin—Nausea—Valproic Acid—epilepsy syndrome	4.26e-05	0.000332	CcSEcCtD
Trabectedin—Vomiting—Pregabalin—epilepsy syndrome	4.12e-05	0.000322	CcSEcCtD
Trabectedin—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.09e-05	0.000319	CcSEcCtD
Trabectedin—Rash—Pregabalin—epilepsy syndrome	4.09e-05	0.000319	CcSEcCtD
Trabectedin—Dermatitis—Pregabalin—epilepsy syndrome	4.08e-05	0.000319	CcSEcCtD
Trabectedin—CYP2E1—head—epilepsy syndrome	4.08e-05	0.0182	CbGeAlD
Trabectedin—Diarrhoea—Gabapentin—epilepsy syndrome	4.07e-05	0.000317	CcSEcCtD
Trabectedin—Headache—Pregabalin—epilepsy syndrome	4.06e-05	0.000317	CcSEcCtD
Trabectedin—Abdominal pain—Topiramate—epilepsy syndrome	3.95e-05	0.000308	CcSEcCtD
Trabectedin—Body temperature increased—Topiramate—epilepsy syndrome	3.95e-05	0.000308	CcSEcCtD
Trabectedin—Dizziness—Gabapentin—epilepsy syndrome	3.93e-05	0.000307	CcSEcCtD
Trabectedin—PTGS1—head—epilepsy syndrome	3.93e-05	0.0175	CbGeAlD
Trabectedin—CYP2E1—nervous system—epilepsy syndrome	3.87e-05	0.0172	CbGeAlD
Trabectedin—Nausea—Pregabalin—epilepsy syndrome	3.85e-05	0.0003	CcSEcCtD
Trabectedin—Vomiting—Gabapentin—epilepsy syndrome	3.78e-05	0.000295	CcSEcCtD
Trabectedin—Rash—Gabapentin—epilepsy syndrome	3.75e-05	0.000292	CcSEcCtD
Trabectedin—Dermatitis—Gabapentin—epilepsy syndrome	3.74e-05	0.000292	CcSEcCtD
Trabectedin—PTGS1—nervous system—epilepsy syndrome	3.72e-05	0.0166	CbGeAlD
Trabectedin—Headache—Gabapentin—epilepsy syndrome	3.72e-05	0.000291	CcSEcCtD
Trabectedin—CYP2E1—central nervous system—epilepsy syndrome	3.72e-05	0.0166	CbGeAlD
Trabectedin—Hypersensitivity—Topiramate—epilepsy syndrome	3.68e-05	0.000287	CcSEcCtD
Trabectedin—CYP2E1—cerebellum—epilepsy syndrome	3.64e-05	0.0162	CbGeAlD
Trabectedin—Asthenia—Topiramate—epilepsy syndrome	3.59e-05	0.00028	CcSEcCtD
Trabectedin—PTGS1—central nervous system—epilepsy syndrome	3.59e-05	0.016	CbGeAlD
Trabectedin—Nausea—Gabapentin—epilepsy syndrome	3.53e-05	0.000275	CcSEcCtD
Trabectedin—Diarrhoea—Topiramate—epilepsy syndrome	3.42e-05	0.000267	CcSEcCtD
Trabectedin—Dizziness—Topiramate—epilepsy syndrome	3.31e-05	0.000258	CcSEcCtD
Trabectedin—CYP2D6—head—epilepsy syndrome	3.23e-05	0.0144	CbGeAlD
Trabectedin—Vomiting—Topiramate—epilepsy syndrome	3.18e-05	0.000248	CcSEcCtD
Trabectedin—Rash—Topiramate—epilepsy syndrome	3.15e-05	0.000246	CcSEcCtD
Trabectedin—Dermatitis—Topiramate—epilepsy syndrome	3.15e-05	0.000246	CcSEcCtD
Trabectedin—Headache—Topiramate—epilepsy syndrome	3.13e-05	0.000244	CcSEcCtD
Trabectedin—CYP3A4—nervous system—epilepsy syndrome	3.11e-05	0.0139	CbGeAlD
Trabectedin—CYP2D6—nervous system—epilepsy syndrome	3.06e-05	0.0137	CbGeAlD
Trabectedin—CYP3A4—central nervous system—epilepsy syndrome	3e-05	0.0134	CbGeAlD
Trabectedin—Nausea—Topiramate—epilepsy syndrome	2.97e-05	0.000232	CcSEcCtD
Trabectedin—CYP2E1—brain—epilepsy syndrome	2.96e-05	0.0132	CbGeAlD
Trabectedin—CYP2D6—central nervous system—epilepsy syndrome	2.95e-05	0.0131	CbGeAlD
Trabectedin—CYP2D6—cerebellum—epilepsy syndrome	2.88e-05	0.0128	CbGeAlD
Trabectedin—PTGS1—brain—epilepsy syndrome	2.85e-05	0.0127	CbGeAlD
Trabectedin—CYP2D6—brain—epilepsy syndrome	2.34e-05	0.0104	CbGeAlD
Trabectedin—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.13e-06	9.48e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.13e-06	9.48e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.13e-06	9.48e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.13e-06	9.48e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.13e-06	9.48e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NPY—epilepsy syndrome	6.12e-06	9.47e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ATP2A2—epilepsy syndrome	6.12e-06	9.47e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—FGF2—epilepsy syndrome	6.06e-06	9.38e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.05e-06	9.37e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—BCL2—epilepsy syndrome	5.99e-06	9.28e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDC42—epilepsy syndrome	5.97e-06	9.23e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.93e-06	9.18e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL18—epilepsy syndrome	5.9e-06	9.14e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HSPB1—epilepsy syndrome	5.9e-06	9.13e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL3—epilepsy syndrome	5.9e-06	9.13e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL2—epilepsy syndrome	5.9e-06	9.13e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—OXT—epilepsy syndrome	5.9e-06	9.13e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CRH—epilepsy syndrome	5.9e-06	9.13e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCG2—epilepsy syndrome	5.9e-06	9.13e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—RELA—epilepsy syndrome	5.86e-06	9.07e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.85e-06	9.05e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.8e-06	8.97e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—FYN—epilepsy syndrome	5.75e-06	8.9e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP2C19—epilepsy syndrome	5.75e-06	8.9e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MTOR—epilepsy syndrome	5.75e-06	8.89e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MEF2C—epilepsy syndrome	5.72e-06	8.86e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP11A1—epilepsy syndrome	5.71e-06	8.84e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.68e-06	8.79e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—MMP9—epilepsy syndrome	5.65e-06	8.75e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.63e-06	8.71e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—RELA—epilepsy syndrome	5.63e-06	8.71e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.6e-06	8.67e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.6e-06	8.67e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.6e-06	8.67e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.58e-06	8.64e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.58e-06	8.64e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—YWHAZ—epilepsy syndrome	5.53e-06	8.56e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—MTOR—epilepsy syndrome	5.52e-06	8.54e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TSC1—epilepsy syndrome	5.49e-06	8.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTK2B—epilepsy syndrome	5.49e-06	8.49e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HES1—epilepsy syndrome	5.46e-06	8.45e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.4e-06	8.37e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.39e-06	8.35e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCR2—epilepsy syndrome	5.34e-06	8.26e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NTRK2—epilepsy syndrome	5.34e-06	8.26e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SST—epilepsy syndrome	5.34e-06	8.26e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—FYN—epilepsy syndrome	5.31e-06	8.22e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—H2AFX—epilepsy syndrome	5.29e-06	8.19e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—DUSP6—epilepsy syndrome	5.29e-06	8.19e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ADRA2A—epilepsy syndrome	5.22e-06	8.08e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.21e-06	8.06e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.21e-06	8.06e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PLAT—epilepsy syndrome	5.2e-06	8.05e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.2e-06	8.05e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP2D6—epilepsy syndrome	5.15e-06	7.98e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.13e-06	7.95e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.13e-06	7.95e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—JUN—epilepsy syndrome	5.13e-06	7.95e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—HMOX1—epilepsy syndrome	5.13e-06	7.94e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—YWHAZ—epilepsy syndrome	5.11e-06	7.9e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.09e-06	7.88e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	5.09e-06	7.88e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	5.09e-06	7.88e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—epilepsy syndrome	5.08e-06	7.86e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CAT—epilepsy syndrome	5.06e-06	7.84e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BDKRB2—epilepsy syndrome	5.02e-06	7.77e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL12—epilepsy syndrome	5.02e-06	7.77e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—epilepsy syndrome	5.02e-06	7.77e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—epilepsy syndrome	4.98e-06	7.71e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CRP—epilepsy syndrome	4.94e-06	7.65e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—TSC2—epilepsy syndrome	4.94e-06	7.65e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JUNB—epilepsy syndrome	4.92e-06	7.62e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CNR1—epilepsy syndrome	4.92e-06	7.62e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ABCB1—epilepsy syndrome	4.92e-06	7.62e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CCR5—epilepsy syndrome	4.91e-06	7.6e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PLCB1—epilepsy syndrome	4.91e-06	7.6e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ADRA2A—epilepsy syndrome	4.91e-06	7.6e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.9e-06	7.58e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—BCHE—epilepsy syndrome	4.89e-06	7.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HTR7—epilepsy syndrome	4.8e-06	7.44e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.76e-06	7.37e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.74e-06	7.34e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HBEGF—epilepsy syndrome	4.66e-06	7.22e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SLC2A1—epilepsy syndrome	4.66e-06	7.22e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.64e-06	7.19e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.64e-06	7.19e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.64e-06	7.19e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PLCB1—epilepsy syndrome	4.61e-06	7.14e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TH—epilepsy syndrome	4.59e-06	7.11e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT3—epilepsy syndrome	4.58e-06	7.09e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GPX1—epilepsy syndrome	4.58e-06	7.09e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—TSC2—epilepsy syndrome	4.57e-06	7.07e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PRKCB—epilepsy syndrome	4.56e-06	7.06e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.55e-06	7.04e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6ST—epilepsy syndrome	4.55e-06	7.04e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ADAM10—epilepsy syndrome	4.47e-06	6.92e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—APOE—epilepsy syndrome	4.47e-06	6.92e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.43e-06	6.86e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.43e-06	6.86e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.41e-06	6.82e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.37e-06	6.77e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TNF—epilepsy syndrome	4.35e-06	6.74e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.33e-06	6.71e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.25e-06	6.57e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—S100B—epilepsy syndrome	4.23e-06	6.55e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6ST—epilepsy syndrome	4.2e-06	6.5e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SOCS3—epilepsy syndrome	4.19e-06	6.48e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.18e-06	6.48e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDC42—epilepsy syndrome	4.18e-06	6.47e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.16e-06	6.45e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—FOS—epilepsy syndrome	4.16e-06	6.45e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS2—epilepsy syndrome	4.16e-06	6.44e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.15e-06	6.42e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.09e-06	6.33e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.08e-06	6.31e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CASP8—epilepsy syndrome	4.07e-06	6.3e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.05e-06	6.27e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AVP—epilepsy syndrome	4.04e-06	6.26e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.04e-06	6.26e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.02e-06	6.22e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AGT—epilepsy syndrome	4.01e-06	6.21e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.99e-06	6.17e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.99e-06	6.17e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.98e-06	6.16e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—APOE—epilepsy syndrome	3.93e-06	6.09e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	3.83e-06	5.94e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HES1—epilepsy syndrome	3.82e-06	5.92e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.82e-06	5.92e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.79e-06	5.86e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CAT—epilepsy syndrome	3.78e-06	5.86e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.77e-06	5.84e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FYN—epilepsy syndrome	3.72e-06	5.76e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.71e-06	5.74e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—H2AFX—epilepsy syndrome	3.71e-06	5.74e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MEF2C—epilepsy syndrome	3.7e-06	5.73e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	3.68e-06	5.7e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—FGF2—epilepsy syndrome	3.68e-06	5.69e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.64e-06	5.63e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.63e-06	5.61e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.6e-06	5.57e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—YWHAZ—epilepsy syndrome	3.58e-06	5.53e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.56e-06	5.51e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TH—epilepsy syndrome	3.54e-06	5.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NGF—epilepsy syndrome	3.54e-06	5.47e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—BCL2—epilepsy syndrome	3.49e-06	5.4e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.49e-06	5.4e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.48e-06	5.39e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.47e-06	5.37e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.45e-06	5.34e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCR5—epilepsy syndrome	3.44e-06	5.32e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.44e-06	5.32e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GPX1—epilepsy syndrome	3.42e-06	5.3e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—RELA—epilepsy syndrome	3.41e-06	5.28e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—FGF2—epilepsy syndrome	3.39e-06	5.25e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—POMC—epilepsy syndrome	3.38e-06	5.23e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HTR2A—epilepsy syndrome	3.37e-06	5.21e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.36e-06	5.2e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.36e-06	5.2e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MTOR—epilepsy syndrome	3.35e-06	5.18e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.31e-06	5.12e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.28e-06	5.08e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.27e-06	5.06e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TH—epilepsy syndrome	3.26e-06	5.05e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.24e-06	5.02e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—epilepsy syndrome	3.24e-06	5.01e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TH—epilepsy syndrome	3.23e-06	5e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TSC2—epilepsy syndrome	3.2e-06	4.95e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGT—epilepsy syndrome	3.19e-06	4.94e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.18e-06	4.93e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—epilepsy syndrome	3.18e-06	4.92e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APOE—epilepsy syndrome	3.13e-06	4.84e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MTOR—epilepsy syndrome	3.09e-06	4.78e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL1B—epilepsy syndrome	3.08e-06	4.78e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALB—epilepsy syndrome	3.08e-06	4.77e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KDR—epilepsy syndrome	3.07e-06	4.74e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—epilepsy syndrome	3.06e-06	4.74e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AGT—epilepsy syndrome	3e-06	4.64e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—JUN—epilepsy syndrome	2.99e-06	4.63e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.96e-06	4.58e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PRKCB—epilepsy syndrome	2.95e-06	4.57e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—APOE—epilepsy syndrome	2.94e-06	4.55e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6ST—epilepsy syndrome	2.94e-06	4.55e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.92e-06	4.52e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—epilepsy syndrome	2.86e-06	4.43e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.84e-06	4.4e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—epilepsy syndrome	2.75e-06	4.25e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.74e-06	4.24e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.72e-06	4.21e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.7e-06	4.18e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—epilepsy syndrome	2.7e-06	4.17e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—POMC—epilepsy syndrome	2.69e-06	4.16e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.68e-06	4.16e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.67e-06	4.13e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.66e-06	4.12e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.65e-06	4.1e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.64e-06	4.09e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL2—epilepsy syndrome	2.63e-06	4.07e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.61e-06	4.04e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.59e-06	4.01e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—POMC—epilepsy syndrome	2.53e-06	3.91e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.43e-06	3.76e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.41e-06	3.73e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.39e-06	3.7e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FGF2—epilepsy syndrome	2.38e-06	3.68e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.31e-06	3.58e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALB—epilepsy syndrome	2.3e-06	3.56e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.28e-06	3.52e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.27e-06	3.51e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.27e-06	3.51e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RELA—epilepsy syndrome	2.21e-06	3.42e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MTOR—epilepsy syndrome	2.16e-06	3.35e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.16e-06	3.35e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.14e-06	3.31e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TH—epilepsy syndrome	2.13e-06	3.3e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.13e-06	3.3e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.11e-06	3.27e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.09e-06	3.23e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.07e-06	3.2e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	2.01e-06	3.12e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—epilepsy syndrome	1.99e-06	3.08e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.95e-06	3.02e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JUN—epilepsy syndrome	1.93e-06	2.99e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—epilepsy syndrome	1.88e-06	2.91e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.79e-06	2.77e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.78e-06	2.75e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.78e-06	2.75e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.78e-06	2.75e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.76e-06	2.72e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.71e-06	2.64e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—epilepsy syndrome	1.69e-06	2.61e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—epilepsy syndrome	1.67e-06	2.58e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.63e-06	2.53e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.62e-06	2.51e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.59e-06	2.46e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	2.41e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—epilepsy syndrome	1.54e-06	2.38e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.43e-06	2.21e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.42e-06	2.19e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.39e-06	2.15e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.36e-06	2.11e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—epilepsy syndrome	1.35e-06	2.1e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.17e-06	1.81e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—epilepsy syndrome	1.08e-06	1.67e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.07e-06	1.65e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—epilepsy syndrome	1.01e-06	1.57e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.34e-07	1.45e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.81e-07	1.21e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.18e-07	1.11e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—epilepsy syndrome	7.12e-07	1.1e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.7e-07	7.27e-06	CbGpPWpGaD
